Indaptus Therapeutics (INDP) SEC Filings & 10K Form

$2.21
-0.14 (-5.96%)
(As of 11:33 AM ET)

Recent Indaptus Therapeutics SEC Filings

DateFilerForm TypeView
03/25/2024
7:31 AM
Indaptus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
4:00 PM
Indaptus Therapeutics (Filer)
Form 424B5
03/13/2024
7:00 AM
Indaptus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
7:02 AM
Indaptus Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/04/2024
10:01 AM
Indaptus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2024
3:15 PM
Indaptus Therapeutics (Issuer)
Newman Michael James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
3:15 PM
Indaptus Therapeutics (Issuer)
Meckler Jeffrey A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
3:15 PM
Indaptus Therapeutics (Issuer)
Sassi Nir (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
3:15 PM
Indaptus Therapeutics (Issuer)
Waltzman Roger J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
3:15 PM
Indaptus Therapeutics (Issuer)
Linscott Walt Addison (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
3:05 PM
Indaptus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2023
3:05 PM
Indaptus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2023
3:06 PM
Indaptus Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2023
7:13 AM
Indaptus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2023
8:12 AM
Indaptus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2023
5:01 PM
Anderson Glen R. (Reporting)
Indaptus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2023
7:10 AM
Indaptus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2023
7:15 AM
Indaptus Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/10/2023
7:45 AM
Indaptus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2023
4:24 PM
Indaptus Therapeutics (Issuer)
Waltzman Roger J. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/07/2023
4:25 PM
Indaptus Therapeutics (Issuer)
Waltzman Roger J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
3:15 PM
Indaptus Therapeutics (Issuer)
MADDALUNA ANTHONY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
3:15 PM
Indaptus Therapeutics (Issuer)
Pomerantz Roger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
3:15 PM
Gilbert Mark John (Reporting)
Indaptus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
3:15 PM
Hayes William B (Reporting)
Indaptus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
3:15 PM
Indaptus Therapeutics (Issuer)
Karah Hila (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2023
6:05 AM
Indaptus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2023
6:10 AM
Indaptus Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:INDP) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners